Drug intelligence / Profile preview

Shenghuang Ketong Ointment

Development stage: Unknown
Lead developer: The First Medical Center of Chinese PLA General Hospital
Modality: Small Molecules, Transdermal Patches → Device-based Delivery → Drug Delivery Systems, Hydrogel Systems → Drug Delivery Systems
Administration: Topical

Overview

Shenghuang Ketong Ointment is a topical pharmaceutical preparation developed by the Chinese People's Liberation Army General Hospital. It is currently in Phase 2 clinical development, with its primary indication being the treatment of herpes zoster (shingles). The specific mechanism of action and active ingredients have not been disclosed in public sources. The ointment represents an investigational therapy aimed at alleviating symptoms associated with herpes zoster, such as pain and skin lesions[1][6].

Brand names: Shenghuang Ketong Ointment
Other names: Shenghuang Ketong

Beyond the preview

Go deeper on Shenghuang Ketong Ointment.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Shenghuang Ketong Ointment.

Explore the full profile